Upexi, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UPXI research report →
About the company
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name.
- CEO
- Allan Marshall
- IPO
- 2021
- Employees
- 59
- HQ
- Tampa, FL, US
Price Chart
- Market Cap
- $61.83M
- P/E
- -0.24
- P/S
- 2.37
- P/B
- -1.11
- EV/EBITDA
- -1.38
- Div Yield
- 0.00%
- Gross Margin
- 86.04%
- Op Margin
- 182.60%
- Net Margin
- -874.01%
- ROE
- -306.96%
- ROIC
- 25.00%
- Revenue
- $15.81M · -39.19%
- Net Income
- $-13,684,209 · 42.16%
- EPS
- $-1.73 · 92.84%
- Op Income
- $-12,499,752
- FCF YoY
- -752.16%
- 52W High
- $10.62
- 52W Low
- $0.54
- 50D MA
- $1.15
- 200D MA
- $2.31
- Beta
- -0.27
- Avg Volume
- 2.89M
Get TickerSpark's AI analysis on UPXI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 23, 25 | MARSHALL ALLAN | buy | 50,000 |
| Dec 16, 25 | MARSHALL ALLAN | buy | 50,000 |
| Dec 15, 25 | MARSHALL ALLAN | buy | 100,000 |
| Oct 1, 25 | MARSHALL ALLAN | other | 1,600,000 |
| Nov 20, 25 | Salkind Gene | buy | 50,000 |
| Oct 1, 25 | Norstrud Andrew James | other | 240,000 |
| Nov 17, 25 | Salkind Gene | buy | 100,000 |
| Nov 17, 25 | Salkind Gene | buy | 100,000 |
| Jul 16, 25 | Salkind Gene | other | 150,000 |
| Jul 16, 25 | Salkind Gene | other | 50,000 |
Our UPXI coverage
Recent articles, reports, and earnings notes.
No research on UPXI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UPXI report →Similar companies
Peers in the same neighborhood.